FDA 510(k)

MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL

N.º K: K252114 · 2025-10-02

Fecha de decisión2025-10-02

Código de productoJWY

Comité asesorMI

DecisiónSubstantially Equivalent

Resumen del dispositivo

MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL is the device name listed in this FDA 510(k) record. The listed applicant is Liofilchem s.r.l.. It received FDA 510(k) clearance on 2025-10-02 under 510(k) number K252114. The device is classified under product code JWY. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL?

MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL is a medical device that received FDA 510(k) clearance on 2025-10-02. The listed applicant is Liofilchem s.r.l.. The 510(k) number is K252114.

When did MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL receive FDA 510(k) clearance?

MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL received FDA 510(k) clearance on 2025-10-02, under 510(k) number K252114.

Who is the listed applicant for MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL?

The FDA 510(k) record lists Liofilchem s.r.l. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL?

The FDA product code for MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL is JWY.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Otros registros que enlistan a Liofilchem s.r.l. como solicitante

K260696MTS Gepotidacin 0.016-256 µg/mL K251580MTS Sulbactam-Durlobactam 0.004/4 - 64/4 µg/mL (SUD)K243202MTS Ceftobiprole 0.002-32 µg/mL K230479ComASP Cefiderocol 0.008-128 K211672MTS Piperacillin-tazobactam 0.016/4 - 256/4µg/mL K200180MTS Omadacycline 0.002 - 32 ug/mL

Ver todos los 35 dispositivos →

Dispositivos relacionados (Código: JWY)

K260447ETEST Gepotidacin (GEP) (0.016-256 µg/mL)bioMérieux SA K260696MTS Gepotidacin 0.016-256 µg/mLLiofilchem s.r.l.K252062El Sistema Sensititre 18-24 hora MIC o Sensibilidad de Punto de Ruptura con Colistina en el rango de dilución de 0.12-16 µg/mLThermo Fisher Scientific K250575The Sensititre 18 - 24 hour MIC or Breakpoint Susceptibility System with Aztreonam/avibactam in the dilution range of 0.008/4 - 64/4 ug/mLThermo Fisher Scientific K252014The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Amikacin in the dilution range of 0.25-256 ug/mLThermo Fisher Scientific K251580MTS Sulbactam-Durlobactam 0.004/4 - 64/4 µg/mL (SUD)Liofilchem s.r.l.

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.